Anthony Clarke
2018
In 2018, Anthony Clarke earned a total compensation of $721.9K as President and Chief Scientific Officer at OncoGenex Pharmaceuticals, a 313% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $183,220 |
|---|---|
| Option Awards | $118,707 |
| Salary | $420,000 |
| Total | $721,927 |
Clarke received $420K in salary, accounting for 58% of the total pay in 2018.
Clarke also received $183.2K in non-equity incentive plan and $118.7K in option awards.
Rankings
In 2018, Anthony Clarke's compensation ranked 10,585th out of 14,244 executives tracked by ExecPay. In other words, Clarke earned more than 25.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,585 out of 14,244 | 26th |
Division Manufacturing | 4,262 out of 5,762 | 26th |
Major group Chemicals And Allied Products | 1,606 out of 2,125 | 24th |
Industry group Drugs | 1,355 out of 1,814 | 25th |
Industry In Vitro and In Vivo Diagnostic Substances | 48 out of 72 | 33rd |
Source: SEC filing on March 28, 2019.
Clarke's colleagues
We found three more compensation records of executives who worked with Anthony Clarke at OncoGenex Pharmaceuticals in 2018.